Skip to main content

Mergers & Acquisitions in Life Sciences — Maximizing Your Returns and Best Practices


Date: September 24, 2015

Time: 3:30AM - 5:30AM

Location: Mintz Levin, 3580 Carmel Mountain Rd., Suite 300, San Diego, CA 92130


  • Mergers & Acquisitions in Life Sciences — Maximizing Your Returns and Best Practices

Please join CohnReznick and Mintz Levin, along with an exclusive group of industry executives, for breakfast and engaging conversation focused on issues critical to M&A transactions in the life sciences industry.

M&A activity in the life sciences sector is vibrant and valuations are favorable for those considering exit via sale.

As a leader of a life sciences company, you need to look to the future and focus on maximizing opportunities and minimizing risk in connection with a sale or acquisition. Come hear from a prestigious panel, featuring Greg Lucier, the current Chairman of the Board and CEO of Nuvasive and the former CEO of Life Technologies at the time of its $13.6 billion sale, which will frame this conversation by sharing their experiences in buying and selling companies in the life sciences space and define the unique issues that those within your industry encounter.






Jeremy Glaser Headshot

Jeremy D. Glaser


Jeremy D. Glaser is Co-chair of Mintz's Venture Capital & Emerging Companies Practice. He has over three decades of experience guiding life sciences and technology companies in growth and financing strategies, including public offerings, financings, mergers and acquisitions, and SEC compliance.

Greg Lucier


Chairman & Chief Executive Officer, NuVasive

Margaret Shanley


Principal, Transactional Advisory Services Practice Leader, Cohn Reznick

John Soden


Managing Director, Houlihan Lokey

Terry Vandewarker


CFO/COO, Ivera Medical Corporation